India is poised to become a global powerhouse in medical technology research and manufacturing, driven by a sweeping digital transformation in healthcare and strategic trade partnerships. This vision was laid out by BVR Subrahmanyam, CEO of Niti Aayog, during his keynote address at the 11th Asia Pacific MedTech Forum 2025 held in New Delhi. The forum, attended by global CEOs, regulators, and innovators, spotlighted India’s rapid ascent in the med-tech sector, underpinned by affordability, scale, and data-driven innovation.
Subrahmanyam emphasized that India’s digital-first approach is generating unprecedented volumes of healthcare data, creating fertile ground for low-cost innovation and global investment. With Free Trade Agreements expanding and policy frameworks aligning with international standards, India is now being seen as a preferred destination for med-tech research, device manufacturing, and digital health solutions.
Key Highlights From The Forum
- India’s healthcare digitization is producing vast datasets, enabling AI-driven innovation
- Price sensitivity in Indian society is driving demand for affordable medical technologies
- Free Trade Agreements with Australia, UAE, and UK are attracting global med-tech firms
- India’s medical device market expected to grow 3–4 times in 5–7 years, and 10–12 times in 25 years
- Med-tech ecosystem now spans semiconductors, diagnostics, manufacturing, and digital platforms
Digital Infrastructure And Data Advantage
India’s healthcare digitization journey has been unique. While many countries are still integrating physical records into digital systems, India has leapfrogged into generating native digital health data. This includes electronic health records, telemedicine logs, wearable device metrics, and real-time diagnostics—all feeding into a vast ecosystem of interoperable platforms.
Subrahmanyam likened this moment to the early days of UPI, which revolutionized digital payments by linking Aadhaar, bank accounts, and mobile numbers. He believes a similar breakthrough is imminent in healthcare, where digital data will catalyze the creation of new products, services, and business models.
Low-Cost Innovation And Market Dynamics
India’s med-tech growth is being propelled by its deeply ingrained price sensitivity. Subrahmanyam noted that affordability is not merely a function of income but a societal mindset. This drives innovation toward frugal engineering, modular design, and scalable solutions that can serve both domestic and global markets.
Startups and established players alike are responding with:
- Portable diagnostic kits for rural outreach
- AI-powered screening tools for early disease detection
- Low-cost surgical instruments and implants
- Remote monitoring systems for chronic care management
These innovations are not only improving access within India but are also being exported to emerging markets across Africa, Southeast Asia, and Latin America.
Global Partnerships And Investment Momentum
India’s expanding network of Free Trade Agreements is playing a pivotal role in attracting foreign investment. By aligning regulatory standards and easing market access, FTAs with countries like Australia, UAE, and the UK are enabling med-tech firms to set up research labs, manufacturing units, and innovation centers in India.
The MedTech Forum also highlighted India’s integration into global supply chains, with semiconductor manufacturing, pharma R&D, and digital health platforms converging to create a robust ecosystem. International CEOs from Stryker, Intuitive Surgical, and Fresenius Medical Care expressed confidence in India’s potential as a long-term innovation partner.
Policy Vision And Future Outlook
The forum’s theme, Swastha Bharat – A Healthier India, Together, aligns with the government’s Healthcare Vision 2030 and Viksit Bharat 2047 roadmap. Key policy priorities include:
- Strengthening regulatory frameworks for medical devices
- Supporting startups through funding and incubation
- Expanding digital health infrastructure in Tier 2 and Tier 3 cities
- Promoting public-private partnerships in R&D and manufacturing
Subrahmanyam concluded that India is not just growing—it is architecting a med-tech future that is inclusive, affordable, and globally competitive.
Sources: Fortune India, SiliconIndia, Express Healthcare
Stay Ahead – Explore Now!
No news available
